KFx raises $10m for cuff repair:
This article was originally published in Clinica
Orthopaedic device manufacturer KFx Medical has secured $10m in a series B financing. The round was led by Alloy Ventures and contributed to by existing shareholders, Charter Life Sciences, Arboretum Ventures, Montreux Equity Partners and MB Venture Partners. The Carlsbad, California-based company will use the funds to aid distribution of its SutureCross knotless anatomic fixation system, which received FDA clearance in August 2006. SutureCross is used for the treatment of double row arthroscopic rotator cuff repair. KFx claims that torn rotator cuffs account for more than 500,000 surgeries every year.
You may also be interested in...
Tensions between industry and the European Commission on the issue of health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future.
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.